Medicare Enrolled

Dr. Ritu Nayar, MD

Cytopathology Physician · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
680 N LAKE SHORE DR, Chicago, IL 60611
3126959797
In practice since 2006 (20 years)
NPI: 1780611632 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nayar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nayar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nayar

Dr. Ritu Nayar is a cytopathology physician in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nayar performed 1,636 Medicare services across 1,241 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nayar received a total of $12,766 from 2 pharmaceutical and/or device companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nayar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,636 Medicare services $12,766 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,636
Medicare services
Bottom 45% in IL for cytopathology physician
1,241
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Cell examination with selective cellular enhancement
A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis.
503 $21 $310
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
169 $30 $204
Intraoperative pathology exam, additional site
A microscopic examination of tissue samples performed during surgery to check for disease. This code applies to each additional site examined beyond the first.
157 $30 $188
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
143 $23 $116
Cell examination of specimen, concentration technique
A laboratory test that uses a concentration technique to examine cells from a specimen.
131 $18 $151
Fine needle aspirate evaluation and report
A pathologist examines cells collected via a fine needle aspiration and provides a written interpretation and report of the findings.
117 $56 $375
Intraoperative pathology examination of specimen
A pathology test performed during surgery to examine a tissue sample from the initial site. The results help guide the surgeon's immediate decisions.
97 $50 $328
Fine needle aspirate evaluation
A laboratory examination of cells collected via fine needle aspiration to assess for abnormalities.
80 $29 $163
Additional Pap test evaluation episode
An additional immediate evaluation of a fine needle aspirate sample during a Pap test procedure.
65 $22 $121
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
53 $28 $356
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 42 $24 $125
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
29 $34 $303
Pathology examination of specimen during surgery
A pathologist examines tissue removed during surgery to determine its nature. This analysis helps guide immediate surgical decisions.
21 $30 $181
Surgical pathology consultation and report, comprehensive
A specialist reviews tissue samples to provide a detailed diagnosis and report.
16 $111 $390
Surgical pathology consultation on referred slides
A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples.
13 $70 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
0.0% medium
98.7% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$12,766
Total received (2018-2023)
Avg $2,553/year across 5 years
Top 6% in IL for cytopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
2
Companies
21
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,485 (66.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,095 (32.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$186 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$33
2022
$153
2020
$2,401
2019
$6,999
2018
$3,179

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Roche Diagnostics Corporation
$33
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Roche Diagnostics Corporation
$6,529
Becton, Dickinson and Company
$6,237
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
BD ONCLARITY · BD Onclarity · CINtec PLUS Cytology · MD cobas Instruments and Reagents · TD BenchMark IHC/ISH and Special Stains Reagents
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cytopathology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cytopathology physician in IL.

Looking for a cytopathology physician in Chicago?
Compare cytopathology physicians in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse cytopathology physicians nearby

Geographic Context

Cytopathology physicians within 10 mi
25
Per 100K population
0.5
County median income
$81,797
Nearest hospital
NORTHWESTERN MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nayar is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nayar experienced with cell examination with selective cellular enhancement?
Based on Medicare claims data, Dr. Nayar performed 503 cell examination with selective cellular enhancement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nayar receive payments from pharmaceutical companies?
Yes. Dr. Nayar received a total of $12,766 from 2 companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nayar's costs compare to other cytopathology physicians in Chicago?
Dr. Nayar's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nayar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →